Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4402881 | 0.80 | TRPA1 (0.37) | TRPA1MAPK1 | |
| SCHEMBL15361787 | 0.79 | TSHR (0.39) | TRPA1TSHR | |
| SCHEMBL20016189 | 0.79 | HSD17B10 (0.42) | TRPA1 | |
| SCHEMBL2454510 | 0.78 | TRPA1 (0.36) | TRPA1TSHRMAPK1 | |
| SCHEMBL4405273 | 0.77 | TRPA1 (0.35) | TRPA1 | |
| SCHEMBL9324017 | 0.75 | TSHR (0.34) | TSHR | |
| SCHEMBL14421166 | 0.75 | LMNA (0.30) | — | |
| SCHEMBL5175834 | 0.75 | USP2 (0.39) | TRPA1 | |
| SCHEMBL20016191 | 0.75 | MEN1 (0.42) | TRPA1TSHRMAPK1 | |
| SCHEMBL24851860 | 0.74 | TRPA1 (0.39) | TRPA1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1380559-B1 | Ethers of 2,2,4-trimethylpentane-1, 3-diol as fragrance materials | TAKASAGO PERFUMERY CO LTD (JP) | 2009-12-23 | — | — | EP | disclosed |
| EP-1380559-B1 | Ethers of 2,2,4-trimethylpentane-1, 3-diol as fragrance materials | TAKASAGO PERFUMERY CO LTD (JP) | 2009-12-23 | — | — | EP | disclosed |
| US-7132391-B2 | Ethers of 2,2,4-trimethylpentane-1,3-diol as fragrance materials | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-11-07 | — | — | US | disclosed |
| US-20040014633-A1 | Ethers of 2,2,4-trimethylpentane-1,3-diol as fragrance materials | TAKASAGO INTERNATIONAL CORPORATION | 2004-01-22 | — | — | US | disclosed |
| EP-1380559-A1 | Ethers of 2,2,4-trimethylpentane-1, 3-diol as fragrance materials | Takasago International Corporation (JP) | 2004-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014633-A1 | Ethers of 2,2,4-trimethylpentane-1,3-diol as fragrance materials | DEGS1, DAGLA, DHCR24 | TRPA1 20/4885TSHR 4040/4885MAPK1 1084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.